Use of quality-adjusted life years for the estimation of effectiveness of health care: A systematic literature review.
about
Nonsteroidal anti-inflammatory drugs, gastroprotection, and benefit-riskReview of studies mapping from quality of life or clinical measures to EQ-5D: an online databaseMelioidosis vaccines: a systematic review and appraisal of the potential to exploit biodefense vaccines for public health purposesEffects of diet modification on meal quality and quality of life in korean diabetic patients: data from Korea national health and nutrition examination survey (2007-2011)Guidelines for screening of extracranial carotid artery disease: a statement for healthcare professionals from the multidisciplinary practice guidelines committee of the American Society of Neuroimaging; cosponsored by the Society of Vascular and InNewborn screening by tandem mass spectrometry for glutaric aciduria type 1: a cost-effectiveness analysis.Domains of quality of life: results of a three-stage Delphi consensus procedure among patients, family of patients, clinicians, scientists and the general public.Economic evaluation of warfarin, dabigatran, rivaroxaban, and apixaban for stroke prevention in atrial fibrillationCost-utility of molecular adsorbent recirculating system treatment in acute liver failure.Validity and responsiveness of the EQ-5D in assessing and valuing health status in patients with anxiety disordersPatient-Centred Innovations for Persons with Multimorbidity: funded evaluation protocol.The validity of the SF-12 and SF-6D instruments in people living with HIV/AIDS in KenyaOne-year mortality, quality of life and predicted life-time cost-utility in critically ill patients with acute respiratory failure.Development and implementation of a telehealth-enhanced intervention for pain and symptom managementA comparison between the EQ-5D and the SF-6D in patients with chronic obstructive pulmonary disease (COPD)Is number sense impaired in chronic pain patients?Redefining the Economics of Geriatric Orthopedics.Measuring preferences for cost-utility analysis: how choice of method may influence decision-makingEstimation of minimally important differences in the EQ-5D and SF-6D indices and their utility in stroke.Benchmarking the burden of 100 diseases: results of a nationwide representative survey within general practicesHealth-related quality of life (EQ-5D) before and after orthopedic surgeryCase vignettes based on EQ-5D to elicit stated preferences for health services utilization from the insurees' perspective.Choosing between measures: comparison of EQ-5D, HUI2 and HUI3 in persons with hearing complaints.Baseline comparison of three health utility measures and the feeling thermometer among participants in the Action to Control Cardiovascular Risk in Diabetes trialBrief case management versus usual care for frequent users of emergency departments: the Coordinated Access to Care from Hospital Emergency Departments (CATCH-ED) randomized controlled trial.Investigating the (cost-) effectiveness of attention bias modification (ABM) for outpatients with major depressive disorder (MDD): a randomized controlled trial protocol.Validation of the EuroQol Five-dimensions - Three-Level Quality of Life Instrument in a Classical Indian Language (Odia) and Its Use to Assess Quality of Life and Health Status of Cancer Patients in Eastern India.Cost-effectiveness analysis for a tele-based health coaching program for chronic disease in primary care.Impact of country-specific EQ-5D-3L tariffs on the economic value of systemic therapies used in the treatment of metastatic pancreatic cancerQuality-adjusted survival following treatment of malignant pleural effusions with indwelling pleural catheters.Multiple health behavior change research: an introduction and overview.Validity and responsiveness of the EQ-5D in assessing and valuing health status in patients with somatoform disorders.Mapping analyses to estimate EQ-5D utilities and responses based on Oxford Knee Score.A comparison of EQ-5D index scores using the UK, US, and Japan preference weights in a Thai sample with type 2 diabetes.Cost effectiveness analysis for nursing research.Impact of schizophrenia and schizophrenia treatment-related adverse events on quality of life: direct utility elicitation.A comparison of health utility scores calculated using United Kingdom and Canadian preference weights in persons with alzheimer's disease and their caregivers.Cost-effectiveness analysis of endovascular versus neurosurgical treatment for ruptured intracranial aneurysms in the United States.Long-term health status as measured by EQ-5D among patients with metastatic breast cancer: comparison of first-line oral S-1 and taxane therapies in the randomized phase III SELECT BC trialEstimating QALY gains in applied studies: a review of cost-utility analyses published in 2010.
P2860
Q26864640-064F3C91-A666-46E6-8D94-C8B145DB3F51Q27026613-1C09EB26-39E3-4045-8A4C-C0AD48EE7ADFQ27305733-62514E68-3715-4DF6-A4CF-694246524584Q30843547-21225806-DDA0-4413-A770-C9FAEBC66F1FQ33154698-90A0B083-F77E-4664-9766-3B08FAF17D79Q33589004-EF2667B3-1ECC-4EBC-9EC6-DBD44CCC6BDDQ33651461-AAF2AD6C-F0AD-448C-8163-5592C0FC4873Q33651588-EC1FFD50-92F3-49D9-A9FB-A650ADD551BBQ33844163-C869BFAF-F699-48FE-BC84-B580C3536E91Q33864811-7696E161-D279-4C0D-94EF-6CA47F906898Q33874746-E133E1B4-7A72-491B-98AD-03E8CE89A002Q33909666-ACFCD436-5FC9-41B2-A662-74D52CE16AD5Q33919235-7270BF48-0288-4390-9B00-05ABEC9DA38AQ33930524-7B1CB92A-9D5A-439A-9ECB-44F3F957F4F7Q34473088-7F5E1793-1674-4350-A6D3-EE59619CB4F4Q34532612-BA0095E7-68D0-430B-9D81-783836A14CCEQ34612629-24204630-E180-457F-BC54-1374B94CE2E8Q34614168-1FC9CD2E-2338-495F-9472-D47351C91A89Q35177004-7DC0B316-32D5-4049-A7B5-AF5FE229B50AQ35564892-1ADC47B9-C3F2-4F27-9A41-7FB0B335A5A4Q35590572-95B8638C-E967-45F1-A061-9CA33A341CDEQ35820830-63BF29AB-C6FF-4D14-9A19-3DECAE15094EQ36087642-A61210B8-4DCA-4697-9774-BE2B5763AB6FQ36091640-C16B50B1-FAD6-45CA-8DE8-573812007CEFQ36111951-93A67E53-A576-457D-A1BE-16A2EA79432AQ36181601-43895FF1-18C4-45CA-91A5-897141DA3D86Q36196450-00FFA302-F40B-4D2E-BAFE-AF3DC27698C4Q36281726-27E0FACB-D8A5-4DB3-AC5D-6BEA905D5314Q36394607-5CB1E05D-7025-438D-8C2B-AB34D82FAB7EQ36411373-851611BE-706E-49C5-A675-4CCE22D7F787Q36528346-C200C274-4179-4644-9742-D90A03838D7EQ36541858-794EFBB2-876E-4E2B-A361-61CA77FEA6EEQ36715015-1792BC2C-4997-414A-BB88-AFB453BBD0F3Q36919790-98DC230A-B14F-4B98-80DF-22F316395E41Q36995970-FF95F682-B949-4C93-BCA8-D40BABB2D05AQ37035804-B468C974-375C-4556-9228-6C7AD6F8FEBDQ37108382-32F17076-BD58-434F-B169-33A643202A07Q37364434-E0F9CE6A-B5F9-4745-A0C0-0202CA175958Q37620096-9A4A8277-4E3B-451B-AD59-EA00E8F0EFC1Q37660468-673D8653-BAEC-4C98-9E86-5B3859F7CC03
P2860
Use of quality-adjusted life years for the estimation of effectiveness of health care: A systematic literature review.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
Use of quality-adjusted life y ...... systematic literature review.
@ast
Use of quality-adjusted life y ...... systematic literature review.
@en
type
label
Use of quality-adjusted life y ...... systematic literature review.
@ast
Use of quality-adjusted life y ...... systematic literature review.
@en
prefLabel
Use of quality-adjusted life y ...... systematic literature review.
@ast
Use of quality-adjusted life y ...... systematic literature review.
@en
P2093
P2860
P1476
Use of quality-adjusted life y ...... systematic literature review.
@en
P2093
Eija Roine
Olli-Pekka Ryynänen
Pirjo Räsänen
Risto Roine
Virpi Semberg-Konttinen
P2860
P304
P356
10.1017/S0266462306051051
P577
2006-01-01T00:00:00Z